COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 1536: Articles 15351-15360  | Next

Homebrew reagents for low cost RT-LAMP
Matute, T., Nunez, I., Rivera, M., Reyes, J., Blazquez-Sanchez, P., Arce, A., Brown, A. J., Gandini, C., Molloy, J., Ramirez-Sarmiento, C. A., Federici, F.
10.1101/2021.05.08.21256891 — Posted: 2021-05-12
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
Reddy, K. P., Fitzmaurice, K. P., Scott, J. A., Harling, G., Lessells, R. J., Panella, C., Shebl, F. M., Freedberg, K. A., Siedner, M. J.
10.1101/2021.05.07.21256852 — Posted: 2021-05-12
Comprehensive and Temporal Surveillance of SARS-CoV-2 in Urban Water Bodies: Early Signal of Second Wave Onset
Hemalatha, M., Tharak, A., Kopperi, H., Kiran, U., Gokulan, C. G., Mishra, R. K., Venkata Mohan, S.
10.1101/2021.05.08.21256881 — Posted: 2021-05-12
Impact of vaccination on the COVID-19 pandemic: Evidence from U.S. states
Chen, X., Huang, H., Ju, J., Sun, R., Zhang, J.
10.1101/2021.05.08.21256892 — Posted: 2021-05-12
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Kabinger, F., Stiller, C., Schmitzova, J., Dienemann, C., Hillen, H. S., Höbartner, C., Cramer, P.
10.1101/2021.05.11.443555 — Posted: 2021-05-11
Dynamic Interactions of Fully Glycosylated SARS-CoV-2 Spike Protein with Various Antibodies
Cao, Y., Choi, Y. K., Frank, M., Woo, H., Park, S.-J., Yeom, M. S., Seok, C., Im, W.
10.1101/2021.05.10.443519 — Posted: 2021-05-11
Design and immunogenicity of a Pan-SARS-CoV-2 synthetic DNA vaccine
Reed, C. C., Schultheis, K., Andrade, V. M., Kalia, R., Tur, J., Schouest, B., Elwood, D., Walters, J. N., Maricic, I., Doan, A., Vazquez, M., Eblimit, Z., Pezzoli, P., Amante, D., Yang, M., Fader, J., Ferrer, R., Weiner, D. B., Kim, J. J., Humeau, L. M., Ramos, S. J., Smith, T. R., Broderick, K. E.
10.1101/2021.05.11.443592 — Posted: 2021-05-11 Discussion: Onsite
Viral shedding and transmission after natural infection and vaccination in an animal model of SARS-CoV-2 propagation
Zeiss, C. J., Asher, J. L., Vander Wyk, B. J., Allore, H. G., Compton, S. J.
10.1101/2021.05.11.443477 — Posted: 2021-05-11
Structure and mechanism of SARS-CoV-2 Spike N679-V687 deletion variant elucidate cell-type specific evolution of viral fitness
Gupta, K., Toelzer, C., Williamson, M. K., Shoemark, D., Oliveira, A. S. F., Matthews, D. A., Almuqrin, A., Staufer, O., Yadav, S. K. N., Borucu, U., Garzoni, F., Fitzgerald, D., Spatz, J., Mulholland, A. J., Davidson, A. D., Schaffitzel, C., Berger, I.
10.1101/2021.05.11.443384 — Posted: 2021-05-11
SARS-CoV-2 Variant Identification Using a Genome Tiling Array and Genotyping Probes
Shimada, R., Alden, E. N., Hoff, K., Ding, D., Sun, J., Halasz, A. M., Zhou, W., Edwards, J. S.
10.1101/2021.05.11.443659 — Posted: 2021-05-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).